ACT with NMOSD Patients and Caregivers Pilot Study

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

November 21, 2024

Conditions
NMO Spectrum Disorder
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

"Acceptance and Commitment Therapy is one potential intervention for reducing internalizing symptoms, increasing purpose in life, and reducing avoidance-based coping among people with NMOSD and their caregiver loved ones. ACT is a third wave behavioral therapy which balances encouraging life changes in the service of one's values (purpose in life) with a strong acceptance component. This novel, experiential, contextual talk therapy is an empirically supported treatment for anxiety and depression, substance use, and has proven successful in managing chronic pain, somatic problems, HIV, Pancreatic Cancer and Cystic Fibrosis."

Trial Locations (1)

19103

Thomas Jefferson University Hospital, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Alexion Pharmaceuticals, Inc.

INDUSTRY

lead

Thomas Jefferson University

OTHER